Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

In situ engineered silicon-magnesium implants orchestrate sequential immunomodulation, angiogenesis, and osteogenesis for bone repair.

Qiang W., Chen M., Ma H., Ai M., Tian J., Zhang Z.

Laboratory Study on Immune Modulation, published in Mater Today Bio (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Mater Today Bio (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42256073
PMCID
PMC13240827
DOI
10.1016/j.mtbio.2026.103205

Abstract (original English)

Magnesium (Mg) is a promising candidate for next-generation bone implants due to its favorable mechanical properties and biodegradability. However, its rapid corrosion causes local alkalization, hydrogen release, and inflammation, severely limiting clinical translation. Herein, we developed a multifunctional Mg-based implant, denoted as Mg/Mg 2 SiO 4 /PDA (MSP), by constructing an in situ Mg 2 SiO 4 interlayer on the Mg substrate through a one-pot hydrothermal process, followed by polydopamine (PDA) functionalization. This multilayered design orchestrates sequential bone regeneration: early antiinfection-immunoregulation and late vascularization and osteogenesis, which main arises from the different degradation rate and time-window effects of the PDA and Mg-Si layers. By harnessing a controlled initial alkaline burst, the implant effectively inhibits bacterial infection, with bacterial survival rates all below 20%, while the subsequent PDA-mediated immunomodulation promotes macrophage polarization toward the pro-regenerative M2 phenotype and suppressing pro-inflammatory cytokines. Concurrently, controlled release of Si 4+ and Mg 2+ from the Mg 2 SiO 4 layer, synergized with PDA, enhances endothelial cell migration and angiogenesis. Sustained Mg 2+ release further supports osteogenesis, amplified by the synergistic effects of Si 4+ and PDA. MSP exhibited effective antioxidative

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research